Mostrando 10 resultados de: 14
Publisher
Journal of Nanobiotechnology(3)
Pharmaceutics(2)
Applied Sciences (Switzerland)(1)
Cancers(1)
Colloids and Surfaces B: Biointerfaces(1)
Área temáticas
Enfermedades(11)
Farmacología y terapéutica(11)
Medicina y salud(8)
Ginecología, obstetricia, pediatría, geriatría(2)
Bioquímica(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(14)
ODS 9: Industria, innovación e infraestructura(13)
ODS 12: Producción y consumo responsables(1)
Origen
scopus(14)
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
ArticleAbstract: Epigallocatechin-3-gallate (EGCG) is a candidate for treatment of Alzheimer's disease (AD) but its iPalabras claves:Alzheimer's disease, APP/PS1 mice, EGCG, Epigallocatechin gallate, PLGA-PEG, Polymeric nanoparticlesAutores:Antoni Camins, Auladell C., Barenys M., Barroso E., Cano A., Chang J.H., Espina M., Ettcheto M., Folch J., García M.L., Kühne B.A., Souto E.M.B., Turowski P.Fuentes:scopusDevelopment and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment
ArticleAbstract: Riluzole-loaded PLGA nanoparticles (RLZ-NPs) were developed to improve the biopharmaceutical profilePalabras claves:Gellan gum, glaucoma, In situ gelling gel, PLGA nanoparticles, riluzoleAutores:Antoni Camins, Cano A., Espina M., Esteruelas G., Ettcheto M., García-Torra V., Halbaut L., Luisa García M., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusExtracellular vesicles, the emerging mirrors of brain physiopathology
ArticleAbstract: Extracellular vesicles are secreted by a wide variety of cells, and their primary functions includePalabras claves:Alzheimer’s disease, exosomes, Extracellular vesicles, Glioblastoma, multiple sclerosis, amyotrophic lateral sclerosis, neurodegenerative diseases, Parkinson’s DiseaseAutores:Antoni Camins, Bernuz M., Boada M., Cano A., de Antonio E.E., Ettcheto M., Martí M., Pividori M.I., Puerta R., Ruíz A., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusEpigallocatechin-3-gallate PEGylated poly(lactic-co-glycolic) acid nanoparticles mitigate striatal pathology and motor deficits in 3-nitropropionic acid intoxicated mice
ArticleAbstract: Aim: To compare free and nanoparticle (NP)-encapsulated epigallocatechin-3-gallate (EGCG) for the trPalabras claves:3-nitropropionic acid, Epigallocatechin-3-gallate, Huntington's disease, neurodegenerative diseases, PLGA-PEG, Polymeric nanoparticlesAutores:Antoni Camins, Auladell C., Barenys M., Cano A., Espina M., Ettcheto M., Folch J., García M.L., Kühne B.A., Sanchez-Lopez E., Souto E.M.B., Turowski P.Fuentes:scopusExosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges
ReviewAbstract: Neurodegenerative diseases constitute a group of pathologies whose etiology remains unknown in manyPalabras claves:exosomes, Extracellular vesicles, Nanomedicine, nanotechnology, neurodegenerative diseasesAutores:Antoni Camins, Boada M., Cano A., Ettcheto M., Muñoz-Morales Á., Ruíz A., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusMemantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: In vitro and in vivo characterization
ArticleAbstract: Background: Memantine, drug approved for moderate to severe Alzheimer's disease, has not shown to bePalabras claves:Alzheimer's disease, APPswe/PS1dE9 mice, astrocytes, BEnd.3, Brain targeting, Memantine, Nanoparticles, β-Amyloid plaquesAutores:Antoni Camins, Calpena A.C., Cano A., Carmona N., Egea M.A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Silva A.M., Souto E.M.B.Fuentes:scopusMemantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
ArticleAbstract: Glaucoma is a multifactorial neurodegenerative disease associated with retinal ganglion cells (RGC)Palabras claves:drug delivery, glaucoma, Memantine, Nanoparticles, PLGA-PEGAutores:Antoni Camins, Calpena A.C., Cordeiro M.F., Davis B.M., Egea M.A., Espina M., Ettcheto M., García M.L., Guo L., Ravindran N., Sanchez-Lopez E., Silva A.M., Souto E.M.B.Fuentes:scopusLipid Nanoparticles for the Posterior Eye Segment
ReviewAbstract: This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, NanostructPalabras claves:Drug transport, lipid nanoparticles, NLC, Ocular barriers, Ocular drug delivery, Posterior segment, SLNAutores:Antoni Camins, Bonilla L., Cano A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Severino P., Souto E.M.B.Fuentes:scopusLipid nanocarriers for hyperproliferative skin diseases
ReviewAbstract: Hyperproliferative skin diseases (HSD) are a group of diseases that include cancers, pre-cancerous lPalabras claves:Antiproliferative drugs, Hyperproliferative skin diseases, lipid nanoparticles, Liposomes, Skin cancerAutores:Cano A., Chorilli M., de Souza A.L.R., Gremião M.P.D., Karczewski J., Kolenyak Fernanda Dos Santos, Sanchez-Lopez E., Souto E.M.B., Staszewski R., Zielińska A.Fuentes:scopusPolymeric nanoparticles as drug delivery systems for dementia
Book PartAbstract: Dementia affects around 50 million people worldwide and it is one of the main causes of disability aPalabras claves:Alzheimer’s disease, dementia, drug delivery, Nanomedicine, PLGA, Polymeric nanoparticlesAutores:Antoni Camins, Cano A., Espina M., Esteruelas G., Ettcheto M., García M.L., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopus